BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29253542)

  • 1. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
    Vedeld HM; Goel A; Lind GE
    Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
    Grady WM; Yu M; Markowitz SD
    Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers.
    Heydari Z; Moeinvaziri F; Mirazimi SMA; Dashti F; Smirnova O; Shpichka A; Mirzaei H; Timashev P; Vosough M
    Eur J Pharmacol; 2024 Jun; 973():176563. PubMed ID: 38593929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers.
    Karpiński P; Sasiadek MM; Blin N
    J Appl Genet; 2008; 49(1):1-10. PubMed ID: 18263964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenetic Alterations in Gastrointestinal Cancers: Diagnostic and Therapeutic Applications].
    Ushijima T; Maeda M; Kawachi A
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):1-7. PubMed ID: 29362296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers.
    Baba Y; Yagi T; Sawayama H; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H
    Digestion; 2018; 97(1):26-30. PubMed ID: 29393154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
    Toiyama Y; Okugawa Y; Goel A
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers.
    Tran MTMT; Yeh KT; Chuang YM; Hsu PY; Low JT; Kumari H; Lee YT; Chen YC; Huang WH; Jin H; Lin SH; Chan MWY
    PLoS One; 2021; 16(4):e0250499. PubMed ID: 33886682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
    Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
    Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic field cancerization in gastrointestinal cancers.
    Baba Y; Ishimoto T; Kurashige J; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Baba H
    Cancer Lett; 2016 Jun; 375(2):360-366. PubMed ID: 26971491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.
    Baba Y; Murata A; Watanabe M; Baba H
    Surg Today; 2014 Oct; 44(10):1807-16. PubMed ID: 24150097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma.
    Cao M; Zhang C; Zhou L
    Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
    Wong CC; Li W; Chan B; Yu J
    Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers.
    Dai X; Sun X; Wu Y; Lv Z; Yu Z; Yuan Y; Sun L
    Dis Markers; 2022; 2022():4570290. PubMed ID: 35242243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
    Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
    Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic epigenetic biomarkers in cancer.
    Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
    Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
    Hashimoto Y; Zumwalt TJ; Goel A
    Epigenomics; 2016 May; 8(5):685-703. PubMed ID: 27102979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors.
    Kong M; Yu X; Guo W; Guo R
    Int J Biol Sci; 2023; 19(15):4834-4848. PubMed ID: 37781524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.